Training: ESAGON (European Institute of Oncology): Difference between revisions
From Beacon
No edit summary |
No edit summary |
||
| Line 6: | Line 6: | ||
'''Target audience:''' Doctors. | '''Target audience:''' Doctors. | ||
'''Cancer areas of interest:''' [[hasCancerType::C51-C58: Female genitalia cancer]]. | '''Cancer areas of interest:''' [[hasCancerType::C51-C58: Female genitalia cancer]]. [https://www.ieo.it/it/FORMAZIONE/IEO-Education/Esagon/About-Us Click here to learn more]. | ||
'''Information:''' [https://www.ieo.it/it/FORMAZIONE/IEO-Education/Esagon/About-Us | '''Information:''' [https://www.ieo.it/it/FORMAZIONE/IEO-Education/Esagon/About-Us Click here to access]. | ||
Revision as of 00:37, 16 May 2024
Go back to European Institute of Oncology page
Primary purpose: To provide advanced post-graduate training in gynaecologic oncology, focusing on innovative technology and a multidisciplinary approach, with a special emphasis on the management of ovarian cancer.
Target audience: Doctors.
Cancer areas of interest: C51-C58: Female genitalia cancer. Click here to learn more.
Information: Click here to access.
